Roche, Novartis, Syngenta, Lonza: the Industrial Base — conclusion

Conclusion

The industrial base of the Basel life sciences consists of two global pharmaceutical groups, Roche and Novartis, an agricultural science group in Chinese state ownership, Syngenta, a contract manufacturer with roots in the Valais, Lonza, and a second tier of listed and private companies in pharmaceuticals, biotechnology, medical technology and chemicals. Since the merger of 1996, the industry has reshaped itself through a long series of spin-offs that created new listed companies and concentrated the large groups on innovative medicines and diagnostics. Its weight in exports, employment, tax revenue and the Swiss stock market makes it a financial pillar of Basel and of Switzerland. The Schweizerhalle disaster of 1986 showed the risks of the chemical industry and led to the Major Accidents Ordinance, the Rhine Action Programme and a strict liability regime for environmental damage, which together shaped the modern regulatory framework.

The concentration of economic power in a few groups gives the canton a strong interest in their success and makes it vulnerable to their decisions. How the groups finance themselves, how they use the capital markets and how they return capital to their shareholders through dividends, buybacks and spin-offs determines much of what the financial centre does with them. Chapter II therefore turns to the corporate finance of the pharmaceutical groups.

For general information only. This article does not constitute legal or tax advice, does not replace advice on an individual case and creates no lawyer-client relationship. It reflects the legal position as of August 2025.

English

Contact

Dr Alexander Ressos, TEP

Rechtsanwalt/Attorney-at-Law

I am a Swiss attorney-at-law and also admitted as a solicitor in Hong Kong and in England & Wales, with almost 25 years of experience.

Together with my multilingual team, including Chinese, Japanese, Korean, Russian, Ukrainian and French native speakers, I advise companies and their owners from around the world on the full range of banking, corporate, commercial and tax law matters in Switzerland, including international tax planning, fiduciary services, and legal family office services including immigration & relocation or real estate investments. My practice has a particular focus on clients from growth and frontier markets in Greater China, Central Asia and the Caucasus, the rest of Asia, the Middle East, Africa and Latin America, and I equally advise clients from Europe and North America. Through an affiliated Swiss trust company, we also take care of the incorporation and ongoing administration of their companies and other structures, including accounting, tax returns and corporate secretarial services, and I serve as a professional director where required. With the support of a network of first-class cooperation partners, I also implement solutions worldwide.

My approach is to act as a trusted advisor who works directly with decision-makers, on an equal footing: I start from what you want to achieve and shape every structure, contract and tax decision around your commercial goals and how it improves your after-tax return. As “lawyers who make it happen”, my team and I stay involved until your company is set up, your structure is in place and your transaction has closed, and we remain available for any follow-on work that may be required. You benefit from bespoke solutions and personal attention, and sound, friendly and practical advice. We are not the lowest-cost provider in the market, nor do we intend to be; our aim is to deliver well-founded, proper solutions and excellent value for money.

Get in touch →

Roche, Novartis, Syngenta, Lonza: the Industrial Base — conclusion

Conclusion

Setting up or expanding in Switzerland?